We found that overexpression of pre-miR-483 inhibits CCl4-induced liver fibrosis by targeting platelet-derived growth factor-β (PDGF-β) and tissue inhibitor of metalloproteinase 2 (TIMP2) in the activation of HSCs. Here, PDGFB is linked to Hepatic fibrosis.